BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 38902867)

  • 21. Lambert-Eaton Myasthenic Syndrome.
    Kesner VG; Oh SJ; Dimachkie MM; Barohn RJ
    Neurol Clin; 2018 May; 36(2):379-394. PubMed ID: 29655456
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pure Ocular Weakness as the Initial Manifestation of Lambert-Eaton Myasthenic Syndrome.
    Katyal N; Govindarajan R
    Cureus; 2017 Dec; 9(12):e2007. PubMed ID: 29507855
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Paraneoplastic cerebellar degeneration and lambert-eaton myasthenia in a patient with merkel cell carcinoma and voltage-gated calcium channel antibodies.
    Pavolucci L; Giannini G; Giannoccaro MP; Foschini MP; Lang B; Avoni P; Tinuper P; Vincent A; Liguori R
    Muscle Nerve; 2017 Nov; 56(5):998-1000. PubMed ID: 28006860
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Non-paraneoplastic voltage-gated calcium channels antibody-mediated cerebellar ataxia responsive to IVIG treatment.
    Rigamonti A; Lauria G; Stanzani L; Mantero V; Andreetta F; Salmaggi A
    J Neurol Sci; 2014 Jan; 336(1-2):169-70. PubMed ID: 24215945
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Conjoint occurrence of GABAB receptor antibodies in Lambert-Eaton myasthenic syndrome with antibodies to the voltage gated calcium channel.
    Dogan Onugoren M; Rauschka H; Bien CG
    J Neuroimmunol; 2014 Aug; 273(1-2):115-6. PubMed ID: 24929678
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neuromuscular paraneoplastic syndromes: the Lambert-Eaton myasthenic syndrome.
    Prommer E
    J Palliat Med; 2010 Sep; 13(9):1159-62. PubMed ID: 20836646
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An interesting collection of paraneoplastic syndromes in a patient with a malignant thymoma.
    Kidher ES; Briceno N; Taghi A; Chukwuemeka A
    BMJ Case Rep; 2012 Jul; 2012():. PubMed ID: 22761203
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term follow-up in infantile-onset lambert-eaton myasthenic syndrome.
    Portaro S; Parisi D; Polizzi A; Ruggieri M; Andreetta F; Bernasconi P; Toscano A; Rodolico C
    J Child Neurol; 2014 Sep; 29(9):NP58-61. PubMed ID: 24114606
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Seronegative nonparaneoplastic Lambert-Eaton myasthenic syndrome].
    Sanadze AG; Sidnev DV; Tumurov DA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(5):77-80. PubMed ID: 28638036
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reduction of P/Q-type calcium channels in the postmortem cerebellum of paraneoplastic cerebellar degeneration with Lambert-Eaton myasthenic syndrome.
    Fukuda T; Motomura M; Nakao Y; Shiraishi H; Yoshimura T; Iwanaga K; Tsujihata M; Eguchi K
    Ann Neurol; 2003 Jan; 53(1):21-8. PubMed ID: 12509844
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lambert-Eaton myasthenic syndrome and solitary cerebellar metastasis in a patient with occult small-cell lung cancer: a rare experience.
    Ray S; Sonthalia N; Kundu S; Maitra S; Saha M; Talukdar A
    BMJ Case Rep; 2012 Mar; 2012():. PubMed ID: 22605710
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Calcium-channel antibodies in the Lambert-Eaton syndrome and other paraneoplastic syndromes.
    Lennon VA; Kryzer TJ; Griesmann GE; O'Suilleabhain PE; Windebank AJ; Woppmann A; Miljanich GP; Lambert EH
    N Engl J Med; 1995 Jun; 332(22):1467-74. PubMed ID: 7739683
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lambert-Eaton syndrome, an unrecognized treatable pediatric neuromuscular disorder: three patients and literature review.
    Hajjar M; Markowitz J; Darras BT; Kissel JT; Srinivasan J; Jones HR
    Pediatr Neurol; 2014 Jan; 50(1):11-7. PubMed ID: 24138947
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment for Lambert-Eaton myasthenic syndrome.
    Maddison P; Newsom-Davis J
    Cochrane Database Syst Rev; 2003; (2):CD003279. PubMed ID: 12804456
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Paraneoplastic cerebellar degeneration and Lambert-Eaton myasthenic syndrome associated with anti P/Q-type voltage-gated calcium channel antibody in a patient with primary double lung cancer].
    Iwanami M; Odaka M; Nakamura T; Hirata K
    Brain Nerve; 2009 Sep; 61(9):1083-7. PubMed ID: 19803409
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Non-small cell lung cancer associated with late-onset Lambert-Eaton myasthenic syndrome and paraneoplastic cerebellar degeneration.
    Cai G; Sun X; Yu J; Meng X; Li J
    Neurol Sci; 2020 May; 41(5):1277-1279. PubMed ID: 31735997
    [No Abstract]   [Full Text] [Related]  

  • 37. [Blood-brain barrier breakdown and autoimmune cerebellar ataxia].
    Shimizu F
    Rinsho Shinkeigaku; 2024 Mar; 64(3):148-156. PubMed ID: 38403685
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SOX1 antibody-related paraneoplastic neurological syndromes: clinical correlates and assessment of laboratory diagnostic techniques.
    Vabanesi M; Pinto AL; Vogrig A; Goncalves D; Rogemond V; Joubert B; Fabien N; Honnorat J; Muñiz-Castrillo S
    J Neurol; 2023 Mar; 270(3):1691-1701. PubMed ID: 36512064
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The association of the Eaton-Lambert myasthenic syndrome and subacute cerebellar degeneration of nonparaneoplastic origin].
    García Castañón I; Corral I; de Blas G; Fernández Ruiz LC
    Med Clin (Barc); 1995 Mar; 104(8):303-5. PubMed ID: 7700091
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Small cell lung cancer associated with paraneoplastic cerebellar degeneration and Lambert-Eaton myasthenic syndrome].
    Fujii M; Tanaka H; Saito T; Kaneko S; Teramoto S; Murakami S; Omote T; Kashiwagi M; Tanaka K; Abe S
    Nihon Kokyuki Gakkai Zasshi; 1999 Dec; 37(12):992-6. PubMed ID: 10707541
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.